Short answer
Vericel Corp (VCEL) filed its Q1 2026 10-Q quarterly report on May 7, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $68M (up 30.1% year over year) with net income of −$6M.
Q1 2026 key financials · XBRL
- Revenue
- $68M
- +30.1% YoY
- Net income
- −$6M
- +44.0% YoY
- Operating margin
- -11.8%
- Gross margin
- 72.0%
- EPS (diluted)
- −$0.12
- +47.8% YoY
Source: XBRL data from the Vericel Corp (VCEL) Q1 2026 10-Q on SEC EDGAR. USD.
Vericel Corp Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $68.425M, up 30.1% YoY from $52.598M, driven by MACI and Epicel volume and price growth
- Gross profit $49.266M, up 35.8% YoY from $36.273M
- Best performer Epicel revenue $10.885M, up 119.3% YoY; weakest NexoBrid revenue $1.142M, down 14.6%
- Operating cash flow $16.383M vs $6.600M YoY; cash, equivalents and restricted cash increased $9.203M
- Outlook: liquidity sufficient through at least 12 months; headwinds include manufacturing scale-up, supply disruptions, reimbursement and geopolitical risks
Risk Factors
- No material risk-factor changes from the December 31, 2025 Form 10-K
- Carried-forward risks could materially adversely affect results of operations or financial condition
- Newly emerging risks remain possible because currently unknown or immaterial factors may impair the business
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Vericel Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.